NewsOrders & DealsGlobal Longlife Hospital Reports Additional Stake Sale by Dhruv Sureshkumar JaniGlobal Longlife Hospital Reports Additional Stake Sale by Dhruv Sureshkumar Jani
Global Longlife Hospital and Research Limited received another substantial shareholding disclosure from Dhruv Sureshkumar Jani for the sale of 50,000 equity shares under SEBI regulations. This follows his previous sale of 1,00,000 shares, bringing his total divestment to 1,50,000 shares and reducing his stake from 9.52% to 8.10% within a week through sequential open market transactions.
*this image is generated using AI for illustrative purposes only.
Global Longlife Hospital & Research has received another substantial acquisition disclosure from Dhruv Sureshkumar Jani regarding the sale of equity shares under SEBI regulations. Following his previous transaction in December, Jani has executed an additional sale of 50,000 equity shares between December 12, 2025 and December 17, 2025, further reducing his stake in the healthcare company.
Latest Transaction Details
The recent disclosure, filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, shows Jani's continued divestment in Global Longlife Hospital and Research Limited. This latest transaction follows his earlier sale of 1,00,000 shares completed between December 10-11, 2025.
| Transaction Parameter | Latest Sale | Previous Sale |
|---|---|---|
| Shares Sold | 50,000 equity shares | 1,00,000 equity shares |
| Transaction Period | December 12 - December 17, 2025 | December 10 - December 11, 2025 |
| Mode of Sale | Open Market | Open Market |
| Regulatory Filing | SEBI Regulation 29(2) | SEBI Regulation 29(2) |
Cumulative Shareholding Impact
With the completion of both transactions, Jani's total divestment amounts to 1,50,000 equity shares within a week. His original holding of 10,00,000 shares (9.52% stake) has been reduced through these sequential sales, demonstrating a systematic reduction in his investment in the company.
| Shareholding Timeline | Shares Held | Percentage Holding |
|---|---|---|
| Before December Sales | 10,00,000 | 9.52% |
| After First Sale (Dec 11) | 9,00,000 | 8.57% |
| After Second Sale (Dec 17) | 8,50,000 | 8.10% |
| Total Shares Sold | 1,50,000 | -1.42% |
Company Structure and Compliance
Global Longlife Hospital and Research Limited maintains its equity share capital structure at ₹10.50 crores, comprising 1,05,00,000 equity shares of ₹10.00 each. The company continues to trade on BSE under scrip code 543520 with ISIN INE0J2K01014.
| Company Details | Specifications |
|---|---|
| Total Equity Capital | ₹10.50 crores |
| Number of Shares | 1,05,00,000 |
| Face Value per Share | ₹10.00 |
| BSE Scrip Code | 543520 |
| ISIN | INE0J2K01014 |
| Sector | Healthcare |
Regulatory Documentation
Both transactions demonstrate full compliance with SEBI's substantial acquisition regulations. Jani, operating from 25 Divine Bunglows, Science City Road, Sola, Ahmedabad, Gujarat, has submitted all required documentation to BSE Limited and the company, ensuring complete regulatory transparency for both sequential transactions. The filings maintain the company's existing capital structure while reflecting the ongoing changes in ownership pattern.
Historical Stock Returns for Global Longlife Hospital & Research
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.44% | -0.21% | +27.74% | -2.02% | -24.84% | -82.79% |
20
